Wells Fargo & Company BRIDGEBIO PHARMA INC Transaction History

Wells Fargo & Company

2,309,000

Previous 13,543,000 82.95%

Previous $0 NaN%

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	N/A	-11,234,000 Reduced 82.95%	2,309,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-1,683,000 Reduced 11.05%	13,543,000 $0
Q2 2024 Aug 13, 2024	BUY	N/A	293,000 Added 1.96%	15,226,000 $0
Q1 2024 May 10, 2024	SELL	N/A	-2,248,000 Reduced 13.08%	14,933,000 $0
Q4 2023 Feb 09, 2024	SELL	N/A	-1,459,000 Reduced 7.83%	17,181,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	2,683,000 Added 16.81%	18,640,000 $0
Q2 2023 Aug 15, 2023	BUY	N/A	2,200,000 Added 15.99%	15,957,000 $0
Q1 2023 May 12, 2023	BUY	N/A	1,600,000 Added 13.16%	13,757,000 $0
Q2 2022 Aug 12, 2022	SELL	N/A	-1,000,000 Reduced 7.6%	12,157,000 $5.47 Million
Q1 2022 May 16, 2022	SELL	N/A	-1,499,000 Reduced 10.23%	13,157,000 $7.73 Million
Q4 2021 Feb 14, 2022	BUY	N/A	7,500,000 Added 104.81%	14,656,000 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	N/A	-8,000,000 Reduced 52.78%	7,156,000 $9.9 Million
Q2 2021 Aug 16, 2021	BUY	N/A	6,311,000 Added 71.35%	15,156,000 $24.8 Million
Q1 2021 May 13, 2021	BUY	N/A	8,845,000 New	8,845,000 $14.7 Million

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.